Most Cancer Drugs Approved in Europe Show No Survival Benefit

Even in the postmarketing period, half of cancers have no evidence of significant survival gain
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gastroenterology, Gynecology, Nursing, Oncology, Pathology, Pharmacy, Pulmonology, Radiology, Surgery, Urology, Journal, Source Type: news